Titre : Syk kinase

Syk kinase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pattern Recognition, Visual
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syk kinase : Questions médicales les plus fréquentes", "headline": "Syk kinase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syk kinase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-01", "dateModified": "2025-04-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syk kinase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protein-tyrosine kinases", "url": "https://questionsmedicales.fr/mesh/D011505", "about": { "@type": "MedicalCondition", "name": "Protein-tyrosine kinases", "code": { "@type": "MedicalCode", "code": "D011505", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.568" } } }, "about": { "@type": "MedicalCondition", "name": "Syk kinase", "alternateName": "Syk Kinase", "code": { "@type": "MedicalCode", "code": "D000072377", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andy Pike", "url": "https://questionsmedicales.fr/author/Andy%20Pike", "affiliation": { "@type": "Organization", "name": "DMPK (A.P., R.M., B.J.) and Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom andrew.pike@astrazeneca.com." } }, { "@type": "Person", "name": "Antonella Pantaleo", "url": "https://questionsmedicales.fr/author/Antonella%20Pantaleo", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy." } }, { "@type": "Person", "name": "Jinhua Wang", "url": "https://questionsmedicales.fr/author/Jinhua%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA." } }, { "@type": "Person", "name": "Jae Youl Cho", "url": "https://questionsmedicales.fr/author/Jae%20Youl%20Cho", "affiliation": { "@type": "Organization", "name": "Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea; Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon, 16419, Republic of Korea; Department of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: jaecho@skku.edu." } }, { "@type": "Person", "name": "Bernard Barlaam", "url": "https://questionsmedicales.fr/author/Bernard%20Barlaam", "affiliation": { "@type": "Organization", "name": "R&D Oncology, AstraZeneca, Cambridge, United Kingdom. Electronic address: Bernard.barlaam2@astrazeneca.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The status and trends of mitochondrial dynamics research: A global bibliometric and visualized analysis.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807837", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10863-023-09959-6" } }, { "@type": "ScholarlyArticle", "name": "Development and validation of the first Canadian Aboriginal syllabics visual acuity chart.", "datePublished": "2023-02-13", "url": "https://questionsmedicales.fr/article/36796441", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcjo.2023.01.009" } }, { "@type": "ScholarlyArticle", "name": "Personality traits and environment: The effects of observing visual art on verbal creativity.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/37301572", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/bs.pbr.2022.12.006" } }, { "@type": "ScholarlyArticle", "name": "Neural and visual processing of social gaze cueing in typical and ASD adults.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36778502", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/2023.01.30.23284243" } }, { "@type": "ScholarlyArticle", "name": "Indoor Location Technology with High Accuracy Using Simple Visual Tags.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36772637", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s23031597" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines et peptides de signalisation intracellulaire", "item": "https://questionsmedicales.fr/mesh/D047908" }, { "@type": "ListItem", "position": 5, "name": "Protein-tyrosine kinases", "item": "https://questionsmedicales.fr/mesh/D011505" }, { "@type": "ListItem", "position": 6, "name": "Syk kinase", "item": "https://questionsmedicales.fr/mesh/D000072377" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syk kinase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syk kinase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syk kinase", "description": "Comment diagnostiquer une dysfonction de la Syk kinase ?\nQuels tests sont utilisés pour évaluer l'activité de la Syk kinase ?\nY a-t-il des biomarqueurs associés à la Syk kinase ?\nQuels symptômes peuvent indiquer un problème avec la Syk kinase ?\nLa Syk kinase est-elle impliquée dans des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syk kinase", "description": "Quels symptômes sont liés à une activation excessive de la Syk kinase ?\nLa Syk kinase affecte-t-elle le système immunitaire ?\nQuels signes cliniques peuvent indiquer une dysfonction de la Syk kinase ?\nLes troubles de la Syk kinase provoquent-ils des symptômes neurologiques ?\nY a-t-il des symptômes associés à des inhibiteurs de la Syk kinase ?", "url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syk kinase", "description": "Peut-on prévenir les dysfonctionnements de la Syk kinase ?\nY a-t-il des mesures préventives pour les maladies liées à la Syk kinase ?\nLes vaccinations influencent-elles la Syk kinase ?\nComment le stress affecte-t-il la Syk kinase ?\nL'exercice physique influence-t-il la Syk kinase ?", "url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syk kinase", "description": "Quels traitements ciblent la Syk kinase ?\nLes traitements de la Syk kinase sont-ils efficaces ?\nQuels médicaments inhibent la Syk kinase ?\nY a-t-il des effets secondaires des traitements de la Syk kinase ?\nComment les traitements de la Syk kinase sont-ils administrés ?", "url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syk kinase", "description": "Quelles complications peuvent survenir avec une dysfonction de la Syk kinase ?\nLa Syk kinase est-elle liée à des cancers ?\nQuels risques sont associés aux inhibiteurs de la Syk kinase ?\nLes complications de la Syk kinase affectent-elles la qualité de vie ?\nY a-t-il des complications neurologiques liées à la Syk kinase ?", "url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syk kinase", "description": "Quels sont les facteurs de risque pour les maladies liées à la Syk kinase ?\nLe tabagisme affecte-t-il la Syk kinase ?\nL'alimentation influence-t-elle la Syk kinase ?\nLe stress est-il un facteur de risque pour la Syk kinase ?\nY a-t-il des prédispositions génétiques liées à la Syk kinase ?", "url": "https://questionsmedicales.fr/mesh/D000072377?mesh_terms=Pattern+Recognition,+Visual&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction de la Syk kinase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de sang peuvent aider à diagnostiquer des anomalies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité de la Syk kinase ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des dosages de protéines spécifiques sont utilisés." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à la Syk kinase ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biomarqueurs comme le phospho-Syk peuvent indiquer son activation." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec la Syk kinase ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes immunitaires ou inflammatoires peuvent suggérer une dysfonction." } }, { "@type": "Question", "name": "La Syk kinase est-elle impliquée dans des maladies spécifiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est liée à des maladies auto-immunes et des cancers." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une activation excessive de la Syk kinase ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une activation excessive peut entraîner des inflammations et des douleurs articulaires." } }, { "@type": "Question", "name": "La Syk kinase affecte-t-elle le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle joue un rôle clé dans la régulation des réponses immunitaires." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer une dysfonction de la Syk kinase ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des infections fréquentes ou des réactions allergiques peuvent apparaître." } }, { "@type": "Question", "name": "Les troubles de la Syk kinase provoquent-ils des symptômes neurologiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des inhibiteurs de la Syk kinase ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des nausées ou des infections peuvent survenir." } }, { "@type": "Question", "name": "Peut-on prévenir les dysfonctionnements de la Syk kinase ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir la santé immunitaire." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour les maladies liées à la Syk kinase ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les facteurs de risque comme le tabagisme peut réduire les maladies associées." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles la Syk kinase ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent moduler l'activité de la Syk kinase dans le système immunitaire." } }, { "@type": "Question", "name": "Comment le stress affecte-t-il la Syk kinase ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut altérer la signalisation de la Syk kinase, affectant l'immunité." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il la Syk kinase ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la fonction immunitaire et la signalisation de Syk." } }, { "@type": "Question", "name": "Quels traitements ciblent la Syk kinase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs de Syk sont utilisés pour traiter certaines maladies auto-immunes." } }, { "@type": "Question", "name": "Les traitements de la Syk kinase sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils montrent des résultats prometteurs dans le contrôle des maladies inflammatoires." } }, { "@type": "Question", "name": "Quels médicaments inhibent la Syk kinase ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme le fostamatinib sont des inhibiteurs spécifiques de Syk." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires des traitements de la Syk kinase ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets comme des troubles gastro-intestinaux et des infections peuvent survenir." } }, { "@type": "Question", "name": "Comment les traitements de la Syk kinase sont-ils administrés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par voie orale ou intraveineuse, selon le médicament." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une dysfonction de la Syk kinase ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections récurrentes et des maladies auto-immunes peuvent survenir." } }, { "@type": "Question", "name": "La Syk kinase est-elle liée à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activation anormale de Syk est associée à certains types de cancers." } }, { "@type": "Question", "name": "Quels risques sont associés aux inhibiteurs de la Syk kinase ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs peuvent augmenter le risque d'infections et de troubles hématologiques." } }, { "@type": "Question", "name": "Les complications de la Syk kinase affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques liées à la Syk kinase ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours pour explorer les liens entre Syk et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies liées à la Syk kinase ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le sexe et des antécédents familiaux peuvent influencer le risque." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la Syk kinase ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut altérer la signalisation de la Syk kinase et augmenter les risques de maladies." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la Syk kinase ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut aider à réguler l'activité de la Syk kinase." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque pour la Syk kinase ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les dysfonctionnements de la Syk kinase." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques liées à la Syk kinase ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines variations génétiques peuvent augmenter le risque de dysfonctionnement de Syk." } } ] } ] }

Sources (10000 au total)

The status and trends of mitochondrial dynamics research: A global bibliometric and visualized analysis.

Mitochondria are remarkably dynamic organelles encapsulated by bilayer membranes. The dynamic properties of mitochondria are critical for energy production.... The aim of our study is to investigate the global status and trends of mitochondrial dynamics research and predict popular topics and directions in the field.... Publications related to the studies of mitochondrial dynamics from 2002 to 2021 were retrieved from Web of Science database. A total of 4,576 publications were included. Bibliometric analysis was cond... There is an increasing trend of mitochondrial dynamics research during the last 20 years. The cumulative number of publications about mitochondrial dynamics research followed the logistic growth model... Attention should be drawn to the latest popular research and more efforts will be put into mechanistic research, which may inspire new clinical treatments for the associated diseases....

Development and validation of the first Canadian Aboriginal syllabics visual acuity chart.

To design and validate the first visual acuity (VA) chart in the Canadian Aboriginal syllabics (CAS) alphabet.... Prospective, nonrandomized, within-subjects cross-sectional study.... Twenty Latin- and CAS-reading subjects were recruited from Ullivik, a residence in Montreal for Inuit patients.... VA charts were made in Latin and in CAS using letters conserved across Inuktitut, Cree, and Ojibwe languages. Fonts were similar in style and size between charts. Each chart was made for a viewing dis... Median best-corrected VAs were 0.04 logMAR (range, -0.06-0.54) and 0.07 logMAR (range, 0-0.54) for the Latin and CAS charts, respectively. Median difference between CAS and Latin charts was 0 logMAR (... We demonstrate here the first VA chart in Canadian Aboriginal syllabics for Inuktitut-, Ojibwe-, and Cree-reading patients. The CAS VA chart has highly similar measurements to the standard Snellen cha...

Neural and visual processing of social gaze cueing in typical and ASD adults.

Atypical eye gaze in joint attention is a clinical characteristic of autism spectrum disorder (ASD). Despite this documented symptom, neural processing of joint attention tasks in real-life social int... Little is known about why it is so difficult for autistic individuals to make eye contact with other people. We find that in a live face-to-face viewing task with a robot, the brains of autistic parti...

Early visual alterations in individuals at-risk of Alzheimer's disease: a multidisciplinary approach.

The earliest pathological features of Alzheimer's disease (AD) appear decades before the clinical symptoms. The pathology affects the brain and the eye, leading to retinal structural changes and funct... In total, 144 healthy subjects: 105 with family history of AD and 39 without, underwent ophthalmologic analysis, magnetoencephalography recording, and genotyping. A subdivision was made to compare gro... High-risk groups showed increased visual acuity. Visual acuity was also related to a lower M100 latency and a greater power time-frequency cluster in the high-risk group. Low-risk groups did not show ... To our knowledge, this paper is the first of its kind, assessing the relationship between ophthalmological and electrophysiological measures in healthy subjects at distinct levels of risk of AD. The r...